Alkalinizing Agent Sodium Bicarbonate 1 mEq / mL, 8.4% Intravenous Injection Single Dose Vial 50 mL , APP Pharmaceuticals 63323008950
$50.00
$44.99
Alkalinizing Agent Sodium Bicarbonate 1 mEq / mL, 8.4% Intravenous Injection Single Dose Vial 50 mL , APP Pharmaceuticals 63323008950
1- REGULATIONS ON PURCHASE OF THESE PRODUCTS VARY FROM STATE TO STATE . IT IS THE PURCHASER'S RESPONSIBILITY TO KNOW AND COMPLY WITH THE LAWS GOVERNING THE DISTRICT IN WHICH THEY LIVE. <BR> 2-THESE ITEMS WOULD BE USED ONLY BY QUALIFIED CUSTOMERS ( PHYSICIAN OFFICES , DIAGNOSTIC & RESEARCH LABORATORIES , HEALTH CARE PROVIDERS , .... ) WITH VALID PROFESSIONAL LICENSE. <BR> 3- ANY INQUIRY REGARDING THESE ITEMS WOULD BE PROCESSED AFTER VERIFICATION OF VALID LICENSE TO BE EMAILED AS AN ATTACHMENT TO : ADMIN@ALLMEDTECH.COM OR FAXED TO 323-782-0985 )
| Manufacturer # | 63323008950 |
| Manufacturer | APP Pharmaceuticals |
| Application | Alkalinizing Agent |
| Container Type | Single Dose Vial |
| Dosage Form | Injection |
| Generic Drug Code | 02792 |
| Generic Drug Name | Sodium Bicarbonate |
| NDC Number | 63323-0089-50 |
| Strength | 1 mEq / mL, 8.4% |
| Type | Intravenous |
| UNSPSC Code | 42161608 |
| Volume | 50 ml |
Features
- Sodium Bicarbonate Injection, USP is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis
- Sodium bicarbonate is further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturate-protein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of blood pigments
- Sodium bicarbonate also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate
Featured Products
